139 related articles for article (PubMed ID: 16764329)
1. [Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure].
Kawashiro N; Matsuda N; Endo Y; Uchida Y; Kasanuki H
J Cardiol; 2006 May; 47(5):229-37. PubMed ID: 16764329
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
[TBL] [Abstract][Full Text] [Related]
3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
4. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
5. Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.
Fujimura M; Akaike M; Iwase T; Yoshida S; Sumitomo Y; Yagi S; Ikeda Y; Hashizume S; Aihara K; Nishiuchi T; Yasumura Y; Matsumoto T
Acta Cardiol; 2009 Oct; 64(5):589-95. PubMed ID: 20058503
[TBL] [Abstract][Full Text] [Related]
6. Heart failure in a district general hospital: are target doses of beta-blockers realistic?
Mehta PA; McDonagh S; Poole-Wilson PA; Grocott-Mason R; Dubrey SW
QJM; 2004 Mar; 97(3):133-9. PubMed ID: 14976270
[TBL] [Abstract][Full Text] [Related]
7. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
8. Does NT-proBNP remain a sensitive biomarker for chronic heart failure after administration of a beta-blocker?
Li N; Li Y; Wang F; Jiang W; Huang J; Xu Z; Hua L; Hua C; Huang Y; Wu Y; Li F
Clin Cardiol; 2007 Sep; 30(9):469-74. PubMed ID: 17803204
[TBL] [Abstract][Full Text] [Related]
9. Clinical status and outcome of Japanese heart failure patients with reduced or preserved ejection fraction treated with carvedilol.
Mori Y; Nishikawa Y; Kobayashi F; Hiramatsu K
Int Heart J; 2013; 54(1):15-22. PubMed ID: 23428919
[TBL] [Abstract][Full Text] [Related]
10. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
Hori M; Nagai R; Izumi T; Matsuzaki M
Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359
[TBL] [Abstract][Full Text] [Related]
12. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.
Krum H; Ninio D; MacDonald P
Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738
[TBL] [Abstract][Full Text] [Related]
13. Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).
Figulla HR; Krzeminska-Pakula M; Wrabec K; Chochola J; Kalmbach C; Fridl P
Int J Cardiol; 2006 Nov; 113(2):153-60. PubMed ID: 16157399
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation.
Pamboukian SV; Aminbakhsh A; Thompson CR; Amin H; Mortimer S; D'yachkova Y; Ignaszweski AP
Clin Transplant; 1999 Oct; 13(5):426-31. PubMed ID: 10515224
[TBL] [Abstract][Full Text] [Related]
15. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W
Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706
[TBL] [Abstract][Full Text] [Related]
17. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
19. CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study.
Grosu A; Senni M; Iacovoni A; Gori M; Cantù F; Bisetti S; De Santo T; De Luca A; Gavazzi A
Acta Cardiol; 2011 Oct; 66(5):573-80. PubMed ID: 22032050
[TBL] [Abstract][Full Text] [Related]
20. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
